Introduction: The sticky platelet syndrome (SPS) is a common cause of thrombosis. There are no prospective studies concerning treatment. Objective: To analyze changes in platelet hyperaggregability of patients with SPS who were given anti-platelet drugs and to assess its association with rethrombosis. Methods: A total of 55 patients with a history of thrombosis and SPS phenotype were prospectively studied before and after treatment with aspirin and/or clopidogrel. Results: Patients were followed for 1 to 129 months, median 13. Of 55 patients, 40 received aspirin, 13 received aspirin þ clopidogrel, and 2 receive
Contains fulltext : 136022.pdf (publisher's version ) (Open Access)BACKGROUND: The...
Background: Recent evidence indicates that patients with multiple myeloma receiving combination chem...
Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the autoantibody directed against ...
Objective: Sticky platelet syndrome (SPS) is a common autosomal dominant inherited platelet disorder...
antiplatelet compounds that are used clinically in patients with thrombosis. However, some patients ...
Background Prasugrel is more effective than clopidogrel in reducing platelet aggregation in acute co...
(1) Background: Prostacyclin analogues (epoprostenol, treprostinil, and iloprost) induce va-sodilati...
Introduction: Sticky platelet syndrome (SPS) is most likely a hereditary thrombophilia characterized...
OBJECTIVE: Sticky platelet syndrome (SPS) is a common autosomal dominant inherited platelet disorder...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
A b s t r a c t Introduction: Coronary artery disease (CAD) is associated with higher platelet activ...
Summary. Prothrombin (factor II) deficiency is a rare autosomal recessive coagulation disorder that ...
Full list of author information is available at the end of the articleBackground Platelets play an i...
Background: The dual antiplatelet therapy with acetylsalicylic acid (ASA) and clopidogrel is the cor...
Platelet activation and aggregation are considered to be central to arterial thrombus formation. Ant...
Contains fulltext : 136022.pdf (publisher's version ) (Open Access)BACKGROUND: The...
Background: Recent evidence indicates that patients with multiple myeloma receiving combination chem...
Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the autoantibody directed against ...
Objective: Sticky platelet syndrome (SPS) is a common autosomal dominant inherited platelet disorder...
antiplatelet compounds that are used clinically in patients with thrombosis. However, some patients ...
Background Prasugrel is more effective than clopidogrel in reducing platelet aggregation in acute co...
(1) Background: Prostacyclin analogues (epoprostenol, treprostinil, and iloprost) induce va-sodilati...
Introduction: Sticky platelet syndrome (SPS) is most likely a hereditary thrombophilia characterized...
OBJECTIVE: Sticky platelet syndrome (SPS) is a common autosomal dominant inherited platelet disorder...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
A b s t r a c t Introduction: Coronary artery disease (CAD) is associated with higher platelet activ...
Summary. Prothrombin (factor II) deficiency is a rare autosomal recessive coagulation disorder that ...
Full list of author information is available at the end of the articleBackground Platelets play an i...
Background: The dual antiplatelet therapy with acetylsalicylic acid (ASA) and clopidogrel is the cor...
Platelet activation and aggregation are considered to be central to arterial thrombus formation. Ant...
Contains fulltext : 136022.pdf (publisher's version ) (Open Access)BACKGROUND: The...
Background: Recent evidence indicates that patients with multiple myeloma receiving combination chem...
Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the autoantibody directed against ...